Insider Transactions Reported by 20 Insiders of REATA PHARMACEUTICALS INC

Location
Plano, TX

There are no Buy or Sell transactions made by insiders since 07 Jan 2025

REATA PHARMACEUTICALS INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Samina Khan SVP, Chief Medical Officer $8,635,455 15 May 2023
Elaine Castellanos VP, Chief Accounting Officer $3,234,218 07 Jun 2021
Jack Nielsen Director $88,490 10 Jun 2021
BIOGEN INC. Other* 28 Jul 2023
MICHAEL D. WORTLEY Chief Legal Officer 26 Sep 2023
WILLIAM ROSE Director 26 Sep 2023
William D. McClellan Jr. Director 26 Sep 2023
Christy J. Oliger Director 26 Sep 2023
Martin Edwards Director 26 Sep 2023
Manmeet Soni COO, CFO and President 26 Sep 2023
Bhaskar Anand SVP, Chief Accounting Officer 26 Sep 2023
Shamim Ruff Director 26 Sep 2023
Antal Rohit Desai Director, 10%+ Owner 26 Sep 2023
R. Kent Jr McGaughy Director, 10%+ Owner 26 Sep 2023
James Warren Huff Chief Executive Officer, Director 26 Sep 2023
Steven Ryder Director 26 Sep 2023
Rajiv Patni EVP, Chief R&D Officer 26 Sep 2023
Dawn Carter Bir Chief Commercial Officer 26 Sep 2023
Colin John Meyer Chief Innovation Officer 26 Sep 2023
Andrea Loewen SVP, Global Regulatory Affairs 26 Sep 2023

Recent Insider Transactions by Companies or Individuals for REATA PHARMACEUTICALS INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.